Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

1
results for

"Junjun Ding"

Article category

Keywords

Publication year

"Junjun Ding"

Review

Artificial intelligence, epidemiology, methodology, or others

A decade of liver organoids: Advances in disease modeling
Yue Liu, Jian-Ying Sheng, Chun-Fang Yang, Junjun Ding, Yun-Shen Chan
Clin Mol Hepatol 2023;29(3):643-669.
Published online March 6, 2023
DOI: https://doi.org/10.3350/cmh.2022.0428
Liver organoids are three-dimensional cellular tissue models in which cells interact to form unique structures in culture. During the past 10 years, liver organoids with various cellular compositions, structural features, and functional properties have been described. Methods to create these advanced human cell models range from simple tissue culture techniques to complex bioengineering approaches. Liver organoid culture platforms have been used in various research fields, from modeling liver diseases to regenerative therapy. This review discusses how liver organoids are used to model disease, including hereditary liver diseases, primary liver cancer, viral hepatitis, and nonalcoholic fatty liver disease. Specifically, we focus on studies that used either of two widely adopted approaches: differentiation from pluripotent stem cells or epithelial organoids cultured from patient tissues. These approaches have enabled the generation of advanced human liver models and, more importantly, the establishment of patient-tailored models for evaluating disease phenotypes and therapeutic responses at the individual level.

Citations

Citations to this article as recorded by  Crossref logo
  • Advances in 3D Organoids and Organ‐on‐a‐Chip Systems for Biomedical Research
    Vignesh Sakthivel, Santhanam Sanjai Dharshan, S. Karthick Raja Namasivayam, Jesu Arockiaraj
    Journal of Biomedical Materials Research Part A.2026;[Epub]     CrossRef
  • Stem Cell–Derived Organoids as a Next‐Generation Platform for Drug Toxicity and Efficacy Testing: Toward Replacing Animal Models in Regulatory Science
    Sungmin Kim, Taeho Lee, Mingu Ryu, Yun‐Gwi Park, Sung‐Hwan Moon
    Journal of Applied Toxicology.2026; 46(4): 1124.     CrossRef
  • Advances in Quality Control of Tumor Organoid Living Biobanks
    Ruyu Fan, Shijin Zhou, Pingping An, Xuanxuan Ye, Meng Yu, Yiran Wang, Cong Wu
    Biopreservation and Biobanking.2026;[Epub]     CrossRef
  • Organoid models in viral hepatitis, primary liver cancer, and non-alcoholic fatty liver disease: Advances and challenges
    Ya-Qin Han, Yun-Yang Xu, Ze Xiang, Qiu-Fang Xu, Fei Gao, Mei-Na Yan, Jian Wu
    Hepatobiliary & Pancreatic Diseases International.2026; 25(2): 134.     CrossRef
  • Macrophage-derived S100A9 drives liver fibrosis in Echinococcus multilocularis infection by up-regulating secreted protein acidic and rich in cysteine (SPARC) in hepatic stellate cells
    Ning Yang, Bowen Shi, Junlong Xue, Hongbin Zhang, Jin Chu, Xue Zhang, Liang Li, Guodong Lü, Xiaojuan Bi, Renyong Lin
    International Journal of Biological Macromolecules.2026; 346: 150624.     CrossRef
  • ​Temporal proteomic profiling of iPSC-derived human liver organoids reveals optimal maturation for drug metabolism and toxicology
    Shu Yang, Jon Hao, Masato Ooka, Menghang Xia
    Scientific Reports.2026;[Epub]     CrossRef
  • Organoids Gone Viral: A Comprehensive Review on Human Organoid Models to Study Viral Pathogenesis
    N. S. Suneesh, Parikshit Bagchi, Anupam Mukherjee
    Viruses.2026; 18(2): 238.     CrossRef
  • Esculetin Improves LPS/D-GalN Induced Acute Liver Injury Through AMPK/SIRT1/PGC-1α Signaling Pathway
    Haoyang Dai, Qinqin Zhang, Pei Chen, Suiqing Chen
    Antioxidants.2026; 15(5): 652.     CrossRef
  • Three Dimensional Biomimetic Liver Models to Reconstitute Metabolic Dysfunction-Associated Steatohepatitis (MASH) In Vitro: Hope and Reality
    Saeedeh Zare Jalise, Sina Habibi, Fateme Alizadeh, Fateme Heidari, Leyla Fath-Bayati
    Journal of Clinical and Experimental Hepatology.2026; 16(5): 103599.     CrossRef
  • From liver organoids to regulatory platforms for precision hepatology: Advances and challenges
    Xi Xu, Caimeng Zhuang, Yuchen Liu, Yang Zhang, Yannan Fang, Frank J. Gonzalez, Tingting Yan, Haiping Hao
    The Innovation Drug Discovery.2026; : 100026.     CrossRef
  • The airway epithelial–immune axis: mechanisms and therapeutic implications
    Zhengyi Zhu, Qiang Li, Binjian Hua
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • Gut–Liver Axis Dysfunction in Alcohol-Associated Liver Disease and the Potential Role of Sheep Yogurt: A Scoping Review and Mechanistic Framework
    Yunfeng Wu, Yulong Zhao, Wenna Yao, Yanyan Yang, Hui Bai, Siqin Bao, Xihe Li, Yongli Song
    Nutrients.2026; 18(15): 2549.     CrossRef
  • Liver Organoids: From Disease Modelling to Regenerative Medicine
    Tiepeng Wang, Xiaotian Qu, Jinhong Si, Junkang Meng, Ting Zhang, Shuliang Niu
    Cell Proliferation.2026;[Epub]     CrossRef
  • Liver organoids: From 3D printing to biomedical applications
    Ying Shi, Xin Han, Zheng Zhang, Jiangtao Xu, Guozhen Liu
    BMEMat.2025;[Epub]     CrossRef
  • Computational and experimental advances in liver-on-a-chip technology for cancer research: a systematic review
    Violeta Carvalho, Mariana Ferreira, Raquel O. Rodrigues, Senhorinha F. C. F. Teixeira, Rui A. Lima
    Biophysical Reviews.2025; 17(1): 151.     CrossRef
  • Revolutionizing liver fibrosis research: the promise of 3D organoid models in understanding and treating chronic liver disease
    Umashanker Navik, Sumeet Kumar Singh, Amit Khurana, Ralf Weiskirchen
    Expert Review of Gastroenterology & Hepatology.2025; 19(2): 105.     CrossRef
  • Liver organoids: Current advances and future applications for hepatology
    Yohan Kim, Minseok Kang, Michael Girma Mamo, Michael Adisasmita, Meritxell Huch, Dongho Choi
    Clinical and Molecular Hepatology.2025; 31(Suppl): S327.     CrossRef
  • Modeling hepatic steatosis with human adult stem cell-derived liver organoids
    Liuyang Zhu, Sen Liu, Ze Wang, Yueyue Yang, Pinsheng Han, Wen Tong, Tianyu Zhao, Libo Wang, Tao Cui, Long Yang, Yamin Zhang
    iScience.2025; 28(5): 112344.     CrossRef
  • “Armed in-vitro retina”-generating microglial retinal organoids, where are we now?
    Yaohong Liu, Lixiong Gao, Wenqian Chen, Yuhan Yan, Zi Ye, Zhaohui Li
    Frontiers in Cell and Developmental Biology.2025;[Epub]     CrossRef
  • Primary Human Tissue Models for Metabolic Dysfunction‐Associated Liver Disease ‐ toward Streamlining Drug Discovery with Patient‐Derived Assays
    Sonia Youhanna, Nayere Taebnia, Yingxin Liang, Ningtao Cheng, Yi Wang, Maurice Michel, Volker M. Lauschke
    Advanced Biology.2025;[Epub]     CrossRef
  • Psychosomatic Disorders, Epigenome, and Gut Microbiota
    Hamid Mostafavi Abdolmaleky, Ahmad Pirani, Giuseppe Pettinato
    Cells.2025; 14(24): 1959.     CrossRef
  • Generation and characterization of mature hepatocyte organoids for liver metabolic studies
    Yuchen Liu, Yaxing Zhou, James Ahodantin, Yu Jin, Juanjuan Zhu, Zhonghe Sun, Xiaolin Wu, Lishan Su, Yingzi Yang
    Journal of Cell Science.2024;[Epub]     CrossRef
  • Generation of in vivo-like multicellular liver organoids by mimicking developmental processes: A review
    Ayumu Okumura, Kenji Aoshima, Naoki Tanimizu
    Regenerative Therapy.2024; 26: 219.     CrossRef
  • Ex Vivo Tools and Models in MASLD Research
    Rallia-Iliana Velliou, Eirini Giannousi, Christiana Ralliou, Eva Kassi, Antonios Chatzigeorgiou
    Cells.2024; 13(22): 1827.     CrossRef
  • Advanced In Vitro Models for Preclinical Drug Safety: Recent Progress and Prospects
    Dileep G. Nair, Ralf Weiskirchen
    Current Issues in Molecular Biology.2024; 47(1): 7.     CrossRef
  • Breast cancer organoids derived from patients: A platform for tailored drug screening
    Yen-Dun Tony Tzeng, Jui-Hu Hsiao, Ling-Ming Tseng, Ming-Feng Hou, Chia-Jung Li
    Biochemical Pharmacology.2023; 217: 115803.     CrossRef
  • 20,520 View
  • 397 Download
  • 28 Web of Science
  • Crossref